Advances in mesenchymal stem cell research in sepsis

Journal of Surgical Research

Volumn 173, Issue 1, 2012, Pages 113-126

  Wannemuehler, Todd J ^a   Manukyan, Mariuxi C ^a   Brewster, Benjamin D ^a   Rouch, Joshua ^a   Poynter, Jeffrey A ^a   Wang, Yue ^a   Meldrum, Daniel R ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b METHODIST HOSPITAL   (United States)

Author keywords

animal sepsis models; cell based therapy; mesenchymal stem cells; sepsis

Indexed keywords

ANTIBIOTIC AGENT; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CELL THERAPY AGENT; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; GLUCOCORTICOID; HYPOXIA INDUCIBLE FACTOR 1; IMIPENEM; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MYELOPEROXIDASE; PROSTAGLANDIN E2; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADAPTIVE IMMUNITY; ANGIOGENESIS; APOPTOSIS; BACTERIAL CLEARANCE; CELL ACTIVATION; CELL HOMING; CELL INTERACTION; CELLULAR IMMUNITY; CHEMOTAXIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE MODEL; DNA REPAIR; DOWN REGULATION; DRUG POTENTIATION; ENDOTOXEMIA; ENZYME ACTIVITY; HEART EJECTION FRACTION; HEART INFARCTION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; KIDNEY FUNCTION; LIVER FUNCTION; LOW DRUG DOSE; LYMPHOCYTOPENIA; MACROPHAGE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MITOCHONDRION; MULTIPLE ORGAN FAILURE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PARACRINE SIGNALING; PERITONITIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY BURST; REVIEW; SEPSIS; STEM CELL RESEARCH; SURVIVAL RATE; SYSTEMATIC REVIEW; UPREGULATION;

ANIMALS; APOPTOSIS; BIOMEDICAL RESEARCH; DISEASE MODELS, ANIMAL; MESENCHYMAL STEM CELL TRANSPLANTATION; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; SEPSIS; TISSUE THERAPY;

EID: 84857050210     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.09.053     Document Type: Review

References (130)

1. G.S. Martin, D.M. Mannino, and S. Eaton The epidemiology of sepsis in the United States from 1979 through 2000 N Engl J Med 348 2003 1546
2. J.E. Parrillo, M.M. Parker, and C. Natanson Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy Ann Intern Med 113 1990 227
3. D.C. Angus, W.T. Linde-Zwirble, and J. Lidicker Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care Crit Care Med 29 2001 1303
4. M.M. Levy, R.P. Dellinger, and S.R. Townsend The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis Intensive Care Med 36 2010 222
5. X. Meng, L. Ao, and Y. Song Signaling for myocardial depression in hemorrhagic shock: Roles of Toll-like receptor 4 and p55 TNF-α receptor Am J Physiol Regul Integr Comp Physiol 288 2005 R600
6. C.A. Dinarello Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock Chest 112 1997 321S
7. E.J. Pulido, B.D. Shames, and D.A. Fullerton Differential inducible nitric oxide synthase expression in systemic and pulmonary vessels after endotoxin Am J Physiol Regul Integr Comp Physiol 278 2000 R1232
8. M. Singer, V. De Santis, and D. Vitale Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation Lancet 364 2004 545
9. E. Abraham Neutrophils and acute lung injury Crit Care Med 31 2003 S195
10. H. Choi, R.H. Lee, and N. Bazhanov Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-{κ}B signaling in resident macrophages Blood 118 2011 330
11. R.S. Hotchkiss, K.W. Tinsley, and I.E. Karl Role of apoptotic cell death in sepsis Scand J Infect Dis 35 2003 585
12. A. Trounson, R.G. Thakar, and G. Lomax Clinical trials for stem cell therapies BMC Med 9 2011 52
13. P.R. Crisostomo, T.A. Markel, and Y. Wang Surgically relevant aspects of stem cell paracrine effects Surgery 143 2008 577
14. D.J. Ceradini, A.R. Kulkarni, and M.J. Callaghan Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 Nat Med 10 2004 858
15. B.R. Weil, M.C. Manukyan, and J.L. Herrmann Mesenchymal stem cells attenuate myocardial functional depression and reduce systemic and myocardial inflammation during endotoxemia Surgery 148 2010 444
16. J. Xu, C.R. Woods, and A.L. Mora Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice Am J Physiol Lung Cell Mol Physiol 293 2007 L131
17. M. Wang, P.R. Crisostomo, and C. Herring Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism Am J Physiol Regul Integr Comp Physiol 291 2006 R880
18. M. Dominici, K. Le Blanc, and I. Mueller Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 8 2006 315
19. L. da Silva Meirelles, P.C. Chagastelles, and N.B. Nardi Mesenchymal stem cells reside in virtually all post-natal organs and tissues J Cell Sci 119 2006 2204
20. A.J. Nauta, and W.E. Fibbe Immunomodulatory properties of mesenchymal stromal cells Blood 110 2007 3499
21. B.R. Weil, M.C. Manukyan, and J.L. Herrmann The immunomodulatory properties of mesenchymal stem cells: Implications for surgical disease J Surg Res 167 2011 78
22. A. Krasnodembskaya, Y. Song, and X. Fang Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37 Stem Cells 28 2010 2229
23. E. Chavakis, C. Urbich, and S. Dimmeler Homing and engraftment of progenitor cells: A prerequisite for cell therapy J Mol Cell Cardiol 45 2008 514
24. L.A. Ortiz, M. Dutreil, and C. Fattman Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury Proc Natl Acad Sci USA 104 2007 11002
25. A. Aicher, W. Brenner, and M. Zuhayra Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling Circulation 107 2003 2134
26. A. Mahmood, D. Lu, and M. Lu Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells Neurosurgery 53 2003 697 discussion 702
27. Z.H. Li, W. Liao, and X.L. Cui Intravenous transplantation of allogeneic bone marrow mesenchymal stem cells and its directional migration to the necrotic femoral head Int J Med Sci 8 2011 74
28. O. Hauger, E.E. Frost, and R. van Heeswijk MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy Radiology 238 2006 200
29. B.R. Weil, J.L. Herrmann, and A.M. Abarbanell Intravenous infusion of mesenchymal stem cells is associated with improved myocardial function during endotoxemia Shock 36 2011 235
30. K. Németh, A. Leelahavanichkul, and P.S. Yuen Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production Nat Med 15 2009 42 49
31. J.J. Minguell, A. Erices, and P. Conget Mesenchymal stem cells Exp Biol Med (Maywood) 226 2001 507
32. V.F. Segers, I. Van Riet, and L.J. Andries Mesenchymal stem cell adhesion to cardiac microvascular endothelium: Activators and mechanisms Am J Physiol Heart Circ Physiol 290 2006 H1370
33. G. Brooke, H. Tong, and J.P. Levesque Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta Stem Cells Dev 17 2008 929 940
34. T. Tondreau, N. Meuleman, and B. Stamatopoulos In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: The role of their migration in injured tissues Cytotherapy 11 2009 559
35. A. De Becker, P. Van Hummelen, and M. Bakkus Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3 Haematologica 92 2007 440
36. C. Ries, V. Egea, and M. Karow MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: Differential regulation by inflammatory cytokines Blood 109 2007 4055
37. K. Tatsumi, H. Otani, and D. Sato Granulocyte-colony stimulating factor increases donor mesenchymal stem cells in bone marrow and their mobilization into peripheral circulation but does not repair dystrophic heart after bone marrow transplantation Circ J 72 2008 1351
38. G.Y. Rochefort, B. Delorme, and A. Lopez Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia Stem Cells 24 2006 2202
39. M.S. Penn, and A.A. Mangi Genetic enhancement of stem cell engraftment, survival, and efficacy Circ Res 102 2008 1471
40. F. Belema-Bedada, S. Uchida, and A. Martire Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2 Cell Stem Cell 2 2008 566
41. J. Ringe, S. Strassburg, and K. Neumann Towards in situ tissue repair: Human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2 J Cell Biochem 101 2007 135
42. G. Chamberlain, J. Fox, and B. Ashton Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing Stem Cells 25 2007 2739
43. A.T. Askari, S. Unzek, and Z.B. Popovic Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy Lancet 362 2003 697
44. Y.L. Zhou, H.F. Zhang, and X.L. Li Increased stromal-cell-derived factor 1 enhances the homing of bone marrow derived mesenchymal stem cells in dilated cardiomyopathy in rats Chin Med J (Engl) 123 2010 3282
45. I. Von Luttichau, M. Notohamiprodjo, and A. Wechselberger Human adult CD34- progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4 Stem Cells Dev 14 2005 329
46. E. Gonzalez-Rey, P. Anderson, and M.A. Gonzalez Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis Gut 58 2009 929
47. D. Zhang, G.C. Fan, and X. Zhou Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium J Mol Cell Cardiol 44 2008 281
48. X. Hu, L. Wei, and T.M. Taylor Hypoxic preconditioning enhances bone marrow mesenchymal stem cell migration via Kv2.1 channel and FAK activation Am J Physiol Cell Physiol 301 2011 C362
49. L.A. Ortiz, F. Gambelli, and C. McBride Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects Proc Natl Acad Sci USA 100 2003 8407
50. D.N. Kotton, A.J. Fabian, and R.C. Mulligan Failure of bone marrow to reconstitute lung epithelium Am J Respir Cell Mol Biol 33 2005 328
51. P.R. Crisostomo, M. Wang, and T.A. Markel Stem cell mechanisms and paracrine effects: Potential in cardiac surgery Shock 28 2007 375
52. S. Aggarwal, and M.F. Pittenger Human mesenchymal stem cells modulate allogeneic immune cell responses Blood 105 2005 1815
53. T. Kinnaird, E. Stabile, and M.S. Burnett Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms Circ Res 94 2004 678
54. R. Mazhari, and J.M. Hare Mechanisms of action of mesenchymal stem cells in cardiac repair: Potential influences on the cardiac stem cell niche Nat Clin Pract Cardiovasc Med 4 Suppl 1 2007 S21
55. F. Tanaka, K. Tominaga, and M. Ochi Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats Life Sci 83 2008 771
56. J.W. Lee, X. Fang, and N. Gupta Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung Proc Natl Acad Sci USA 106 2009 16357
57. S.H. Mei, S.D. McCarter, and Y. Deng Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1 PLoS Med 4 2007 e269
58. N. Gupta, X. Su, and B. Popov Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice J Immunol 179 2007 1855
59. G.M. Spaggiari, A. Capobianco, and H. Abdelrazik Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: Role of indoleamine 2,3-dioxygenase and prostaglandin E2 Blood 111 2008 1327
60. K. English, J.M. Ryan, and L. Tobin Cell contact, prostaglandin E(2) and transforming growth factor β 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells Clin Exp Immunol 156 2009 149
61. G.M. Spaggiari, H. Abdelrazik, and F. Becchetti MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: Central role of MSC-derived prostaglandin E2 Blood 113 2009 6576
62. K. Chen, D. Wang, and W.T. Du Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism Clin Immunol 135 2010 448
63. R.S. Hotchkiss, and D.W. Nicholson Apoptosis and caspases regulate death and inflammation in sepsis Nat Rev Immunol 6 2006 813
64. M. Xu, R. Uemura, and Y. Dai In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function J Mol Cell Cardiol 42 2007 441
65. X. Hu, S.P. Yu, and J.L. Fraser Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis J Thorac Cardiovasc Surg 135 2008 799
66. W. Li, N. Ma, and L.L. Ong Bcl-2 engineered MSCs inhibited apoptosis and improved heart function Stem Cells 25 2007 2118
67. E. Dernbach, C. Urbich, and R.P. Brandes Antioxidative stress-associated genes in circulating progenitor cells: Evidence for enhanced resistance against oxidative stress Blood 104 2004 3591
68. M. Ramalho-Santos, S. Yoon, and Y. Matsuzaki "Stemness": Transcriptional profiling of embryonic and adult stem cells Science 298 2002 597
69. N.B. Ivanova, J.T. Dimos, and C. Schaniel A stem cell molecular signature Science 298 2002 601
70. I. Vanhorebeek, R. De Vos, and D. Mesotten Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients Lancet 365 2005 53
71. M.C. Manukyan, B.R. Weil, and Y. Wang Female stem cells are superior to males in preserving myocardial function following endotoxemia Am J Physiol Regul Integr Comp Physiol 300 2011 R1506
72. P.R. Crisostomo, M. Wang, and C.M. Herring Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: Role of the 55 kDa TNF receptor (TNFR1) J Mol Cell Cardiol 42 2007 142
73. P.R. Crisostomo, T.A. Markel, and M. Wang In the adult mesenchymal stem cell population, source gender is a biologically relevant aspect of protective power Surgery 142 2007 215
74. P.R. Crisostomo, M. Wang, and C.M. Herring Sex dimorphisms in activated mesenchymal stem cell function Shock 26 2006 571
75. H. Yagi, A. Soto-Gutierrez, and Y. Kitagawa Bone marrow mesenchymal stromal cells attenuate organ injury induced by LPS and burn Cell Transplant 19 2010 823
76. S.H. Mei, J.J. Haitsma, and C.C. Dos Santos Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis Am J Respir Crit Care Med 182 2010 1047
77. J.A. Poynter, J.L. Herrmann, and M.C. Manukyan Intracoronary mesenchymal stem cells promote postischemic myocardial functional recovery, decrease inflammation, and reduce apoptosis via a signal transducer and activator of transcription 3 mechanism J Am Coll Surg 213 2011 253
78. X. Wang, M.N. Jameel, Q. Li, and A. Mansoor Stem cells for myocardial repair with use of a transarterial catheter Circulation 120 2009 S238
79. M. Gnecchi, H. He, and N. Noiseux Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement FASEB J 20 2006 661
80. S. Ohnishi, T. Yasuda, and S. Kitamura Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells Stem Cells 25 2007 1166
81. S. Vandervelde, M.J. van Luyn, and R.A. Tio Signaling factors in stem cell-mediated repair of infarcted myocardium J Mol Cell Cardiol 39 2005 363
82. Y. Wang, M. Wang, and A.M. Abarbanell MEK mediates the novel cross talk between TNFR2 and TGF-EGFR in enhancing vascular endothelial growth factor (VEGF) secretion from human mesenchymal stem cells Surgery 146 2009 198
83. P.R. Crisostomo, Y. Wang, and T.A. Markel Human mesenchymal stem cells stimulated by TNF-α, LPS, or hypoxia produce growth factors by an NF κ B- but not JNK-dependent mechanism Am J Physiol Cell Physiol 294 2008 C675
84. W. Fan, R. Crawford, and Y. Xiao The ratio of VEGF/PEDF expression in bone marrow mesenchymal stem cells regulates neovascularization Differentiation 81 2011 181
85. Y.L. Tang, Q. Zhao, and X. Qin Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction Ann Thorac Surg 80 2005 229 discussion 236
86. U. Johansson, I. Rasmusson, and S.P. Niclou Formation of composite endothelial cell-mesenchymal stem cell islets: A novel approach to promote islet revascularization Diabetes 57 2008 2393
87. B.M. Beckermann, G. Kallifatidis, and A. Groth VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma Br J Cancer 99 2008 622
88. J. Tang, J. Wang, and X. Kong Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway Exp Cell Res 315 2009 3521
89. D. Zisa, A. Shabbir, and G. Suzuki Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair Biochem Biophys Res Commun 390 2009 834
90. C. Urbich, A. Aicher, and C. Heeschen Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells J Mol Cell Cardiol 39 2005 733
91. J. Kim, and P. Hematti Mesenchymal stem cell-educated macrophages: A novel type of alternatively activated macrophages Exp Hematol 37 2009 1445
92. M.V. Parsey, R.M. Tuder, and E. Abraham Neutrophils are major contributors to intraparenchymal lung IL-1 β expression after hemorrhage and endotoxemia J Immunol 160 1998 1007
93. S. Sookhai, J.J. Wang, and M. McCourt A novel therapeutic strategy for attenuating neutrophil-mediated lung injury in vivo Ann Surg 235 2002 285
94. M.A. Matthay, and R.L. Zemans The acute respiratory distress syndrome: Pathogenesis and treatment Annu Rev Pathol 6 2011 147
95. L. Raffaghello, G. Bianchi, and M. Bertolotto Human mesenchymal stem cells inhibit neutrophil apoptosis: A model for neutrophil preservation in the bone marrow niche Stem Cells 26 2008 151
96. A. Corcione, F. Benvenuto, and E. Ferretti Human mesenchymal stem cells modulate B-cell functions Blood 107 2006 367
97. I. Rasmusson, K. Le Blanc, and B. Sundberg Mesenchymal stem cells stimulate antibody secretion in human B cells Scand J Immunol 65 2007 336
98. G. Ren, L. Zhang, and X. Zhao Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide Cell Stem Cell 2 2008 141
99. M. Di Nicola, C. Carlo-Stella, M. Magni, M. Milanesi, and P.D. Longoni Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli Blood 99 2002 3838
100. K. Le Blanc, I. Rasmusson, and C. Gotherstrom Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes Scand J Immunol 60 2004 307
101. I. Rasmusson, O. Ringden, and B. Sundberg Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms Exp Cell Res 305 2005 33
102. M. Di Ianni, B. Del Papa, and M. De Ioanni Mesenchymal cells recruit and regulate T regulatory cells Exp Hematol 36 2008 309
103. C. Prevosto, M. Zancolli, and P. Canevali Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction Haematologica 92 2007 881
104. R. Maccario, M. Podesta, and A. Moretta Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype Haematologica 90 2005 516
105. A.J. Nauta, A.B. Kruisselbrink, and E. Lurvink Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells J Immunol 177 2006 2080
106. R. Ramasamy, H. Fazekasova, and E.W. Lam Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle Transplantation 83 2007 71
107. G.M. Spaggiari, A. Capobianco, and S. Becchetti Mesenchymal stem cell-natural killer cell interactions: Evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation Blood 107 2006 1484
108. F. Liotta, R. Angeli, and L. Cosmi Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling Stem Cells 26 2008 279
109. C.A. Opitz, U.M. Litzenburger, and C. Lutz Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-β and protein kinase R Stem Cells 27 2009 909
110. R.S. Waterman, S.L. Tomchuck, and S.L. Henkle A new mesenchymal stem cell (MSC) paradigm: Polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype PLoS One 5 2010 e10088
111. A. Nijnik, and R.E. Hancock The roles of cathelicidin LL-37 in immune defences and novel clinical applications Curr Opin Hematol 16 2009 41
112. R. Bucki, K. Leszczynska, and A. Namiot Cathelicidin LL-37: A multitask antimicrobial peptide Arch Immunol Ther Exp (Warsz) 58 2010 15
113. D.M. Bowdish, D.J. Davidson, and R.E. Hancock Immunomodulatory properties of defensins and cathelicidins Curr Top Microbiol Immunol 306 2006 27
114. D. Rittirsch, L.M. Hoesel, and P.A. Ward The disconnect between animal models of sepsis and human sepsis J Leukoc Biol 81 2007 137
115. D.G. Remick, D.E. Newcomb, and G.L. Bolgos Comparison of the mortality and inflammatory response of two models of sepsis: Lipopolysaccharide versus cecal ligation and puncture Shock 13 2000 110
116. S. Maier, T. Traeger, and M. Entleutner Cecal ligation and puncture versus colon ascendens stent peritonitis: Two distinct animal models for polymicrobial sepsis Shock 21 2004 505
117. K.D. Singleton, and P.E. Wischmeyer Distance of cecum ligated influences mortality, tumor necrosis factor-α and interleukin-6 expression following cecal ligation and puncture in the rat Eur Surg Res 35 2003 486
118. E. Otero-Anton, A. Gonzalez-Quintela, and A. Lopez-Soto Cecal ligation and puncture as a model of sepsis in the rat: Influence of the puncture size on mortality, bacteremia, endotoxemia and tumor necrosis factor α levels Eur Surg Res 33 2001 77
119. M.K. Lustig, V.H. Bac, and D. Pavlovic Colon ascendens stent peritonitis-A model of sepsis adopted to the rat: Physiological, microcirculatory and laboratory changes Shock 28 2007 59
120. K.A. Wichterman, A.E. Baue, and I.H. Chaudry Sepsis and septic shock-A review of laboratory models and a proposal J Surg Res 29 1980 189
121. A.J. Nauta, G. Westerhuis, and A.B. Kruisselbrink Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting Blood 108 2006 2114
122. W.T. Tse, J.D. Pendleton, and W.M. Beyer Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation Transplantation 75 2003 389
123. B. Zeng, G. Lin, and X. Ren Over-expression of HO-1 on mesenchymal stem cells promotes angiogenesis and improves myocardial function in infarcted myocardium J Biomed Sci 17 2010 80
124. J. Tan, B.R. Weil, and A.M. Abarbanell Ablation of TNF-α receptors influences mesenchymal stem cell-mediated cardiac protection against ischemia Shock 34 2010 236
125. T. Shu, B. Zeng, and X. Ren HO-1 modified mesenchymal stem cells modulate MMPs/TIMPs system and adverse remodeling in infarcted myocardium Tissue Cell 42 2010 217
126. J.L. Herrmann, Y. Wang, and A.M. Abarbanell Preconditioning mesenchymal stem cells with transforming growth factor-α improves mesenchymal stem cell-mediated cardioprotection Shock 33 2010 24
127. J.L. Herrmann, A.M. Abarbanell, and B.R. Weil Postinfarct intramyocardial injection of mesenchymal stem cells pretreated with TGF-α improves acute myocardial function Am J Physiol Regul Integr Comp Physiol 299 2010 R371
128. M. Wang, J. Tan, and Y. Wang IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction Proc Natl Acad Sci USA 106 2009 17499
129. M. Gnecchi, H. He, and L.G. Melo Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction Stem Cells 27 2009 971
130. G.S. Erwin, P.R. Crisostomo, and Y. Wang Estradiol-treated mesenchymal stem cells improve myocardial recovery after ischemia J Surg Res 152 2009 319